New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
AgeX Therapeutics, Inc.
AGE
Shape
US Flag

AMEX

Unprofitable

Unprofitable

28M

Biotechnology

Next Earning date - 11 Nov 2024

28M

Biotechnology

Next Earning date - 11 Nov 2024

11.10USD
Shape-1.50 ( -11.90%)
favorite-chart

Relative Strenght

4
favorite-chart

Volume Buzz

-8%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

68%

Quote Panel

Shape
Updated October 12, 2024
1W % 1M % 3M % 1Y -56.16 %

Key Metrics

Shape
  • Market Cap

    27.76M


  • Shares Outstanding

    2.50M


  • Share in Float

    2.45M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    11.1


  • Average Volume

    3980


  • Beta

    1.187


  • Range

    10.902699-35.17


  • Industry

    Biotechnology


  • Website

    https://www.agexinc.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

239.30x

P/S Ratio

-7.19x

P/B Ratio

-0.1

Debt/Equity

-18071.6%

Net Margin

$-482.5

EPS

How AGE compares to sector?

P/E Ratio

Relative Strength

Shape

AGE

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-2.46
vs -2.46

Q3.22

arrow
arrow

N/A

-2.11
vs -1.76

Q4.22

arrow
arrow

N/A

NA
vs -0.09

Q1.23

arrow
arrow

N/A

-2.46
vs NA

Q2.23

arrow
arrow

N/A

-2.46
vs -2.46

Q3.23

arrow
arrow

N/A

NA
vs -2.11

Q4.23

arrow
arrow

N/A

-3.20
vs NA

Q1.24

arrow
arrow

N/A

-3.38
vs -2.46

Q3.24

arrow
arrow

N/A

1.34
vs NA

Q4.24

arrow
arrow

+148%

1.54
vs -3.20

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

-68%

12K  vs 37K

Q3.22

arrow
arrow

-62%

9K  vs 24K

Q4.22

arrow
arrow

-70%

8K  vs 27K

Q1.23

arrow
arrow

+100%

10K  vs 5K

Q2.23

arrow
arrow

-25%

9K  vs 12K

Q3.23

arrow
arrow

+411%

46K  vs 9K

Q4.23

arrow
arrow

+600%

56K  vs 8K

Q1.24

arrow
arrow

-50%

5K  vs 10K

Q3.24

arrow
arrow

-90%

4.8K  vs 46K

Q4.24

arrow
arrow

-92%

4.6K  vs 56K

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

+28%

0.28
vs 0.29

Q3.22

arrow
arrow

+22%

0.22
vs 0.28

Q4.22

arrow
arrow

+16%

0.16
vs 0.22

Q1.23

arrow
arrow

+28%

0.28
vs 0.16

Q2.23

arrow
arrow

+12%

0.12
vs 0.28

Q3.23

arrow
arrow

+20%

0.2
vs 0.12

Q4.23

arrow
arrow

-63%

-0.63
vs 0.2

Q1.24

arrow
arrow

+219%

2.19
vs -0.63

Institutionnal OwnershipShape

status-upQoQ

Q1.22

arrow
arrow

25

25
vs 28

-11%

Q2.22

arrow
arrow

24

24
vs 25

-4%

Q3.22

arrow
arrow

23

23
vs 24

-4%

Q4.22

arrow
arrow

29

29
vs 23

26%

Q1.23

arrow
arrow

32

32
vs 29

10%

Q2.23

arrow
arrow

31

31
vs 32

-3%

Q3.23

arrow
arrow

29

29
vs 31

-6%

Q4.23

arrow
arrow

35

35
vs 29

21%

Earnings Growth

Latest News